Ruikang Diagnostics (CN)

Ascendas Genomics develops genetic solutions for diagnostic markets, provides technical and consulting services to clinical research laboratories, academic institutions and biotechnology companies, and offers immunodiagnostic and molecular diagnostic tests to hospitals and health care centers through its subsidiary company, Ruikang Diagnostics, a commercial reference lab. The company aims to be an influential player in the development and application of genetic diagnosis-related products, especially in the field of newborn screening and oncology genetic tests. *

	Start	2017-07-27 existent
	Group	Ascendas Genomics (Group)
	Industry	BIOTECH
	Industry 2	molecular diagnostics

	City	n. a.
		Address record changed: 2017-07-29

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Fluidigm Corporation. (7/27/17). "Press Release: Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China". South San Francisco, CA & Zhongshan.

		Record changed: 2019-06-09

More documents for Ascendas Genomics (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com